Zobrazeno 1 - 10
of 184
pro vyhledávání: '"Marja-Liisa Dahl"'
Autor:
Tigist Dires Gebreyesus, Eyasu Makonnen, Nigus Fikrie Telele, Abbie Barry, Rajabu Hussein Mnkugwe, Heran Gerba, Marja-Liisa Dahl, Eleni Aklillu
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Metabolism of praziquantel (PZQ), a racemic mixture and the only drug approved to treat S. mansoni infection, is mediated by genetically polymorphic enzymes. Periodic school-based mass drug administration (MDA) with PZQ is the core intervent
Externí odkaz:
https://doaj.org/article/2bafea5de4f74380983c947626a0106c
Autor:
Annica Börjesson, Margaretha Ekebergh, Marja-Liisa Dahl, Lena Ekström, Mikael Lehtihet, Veronica Vicente
Publikováno v:
International Journal of Qualitative Studies on Health & Well-Being, Vol 19, Iss 1 (2024)
Purpose Anabolic androgenic steroids (AAS) are used for their aesthetic and performance-enhancing effects and are associated with physical and psychological side effects. Behavioural changes/side effects as mood swings, aggressiveness, depression, po
Externí odkaz:
https://doaj.org/article/7a11aabf4b584fc298a451ef56ec2e83
Autor:
Marja-Liisa Dahl, Karin Leander, Max Vikström, Clara Frumerie, Sofia Nordenmalm, Jette Möller, Karin Söderberg-Löfdal
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract Drug-drug interactions have been shown to affect the risk of fall injuries when opioids are used concomitantly with drugs inhibiting the cytochrome P450 2D6 (CYP2D6) enzyme in a previous pharmacoepidemiological study. The aim of this study w
Externí odkaz:
https://doaj.org/article/a1dcb09dcc0348319a95a414eca616ad
Publikováno v:
Frontiers in Reproductive Health, Vol 3 (2021)
Anabolic Androgenic Steroid (AAS) abuse in the society is considered a health problem and has been associated with cardiovascular toxicity, endocrine disruption, as well as psychiatric symptoms such as aggression and cognitive dysfunction. Men and wo
Externí odkaz:
https://doaj.org/article/5f63514fa79945638c5187c3c894ff0b
Autor:
Annica Börjesson, Margaretha Ekebergh, Marja-Liisa Dahl, Lena Ekström, Mikael Lehtihet, Veronica Vicente
Publikováno v:
Frontiers in Sports and Active Living, Vol 3 (2021)
Anabolic androgenic steroids are used by women to increase their muscle mass and because of their performance-enhancing effects. Despite permanent/high risk of side effects, knowledge is inadequate. Our aim has been to deepen understanding about wome
Externí odkaz:
https://doaj.org/article/d948514e733349acb500608c34621e8a
Autor:
Annica Börjesson, Margaretha Ekebergh, Marja-Liisa Dahl, Lena Ekström, Mikael Lehtihet, Veronica Vicente
Publikováno v:
International Journal of Qualitative Studies on Health & Well-Being, Vol 16, Iss 1 (2021)
Purpose: Anabolic androgenic steroids (AAS) are used by men for their aesthetic and performance-enhancing effects and are associated with risk for side effects. Our research aims to deepen knowledge and understanding of men´s experiences of using AA
Externí odkaz:
https://doaj.org/article/0ff6d75f2c544b7fae5257ec2cfc7d26
Autor:
Annica Börjesson, Christian Möller, Anders Hagelin, Veronica Vicente, Anders Rane, Mikael Lehtihet, Marja-Liisa Dahl, Nina Gårevik, Lena Ekström
Publikováno v:
Medicina, Vol 56, Iss 6, p 265 (2020)
Background and objectives: Anabolic androgenic steroids (AAS) are mainly used for aesthetic and performance-enhancing reasons. Their use is a growing public health problem and concern for society because of their adverse effects. The primary aim of t
Externí odkaz:
https://doaj.org/article/7702684d35144cb292dc395758dfb18b
Autor:
Sandra Soeria-Atmadja, Emma Österberg, Lars L Gustafsson, Marja-Liisa Dahl, Jaran Eriksen, Johanna Rubin, Lars Navér
Publikováno v:
PLoS ONE, Vol 12, Iss 9, p e0181316 (2017)
Approximately 2.6 million children live with HIV globally, and efavirenz (EFV) is one of the most widely used antiretroviral agents for HIV treatment in children and adults. There are concerns about the appropriateness of current EFV dosing and it ha
Externí odkaz:
https://doaj.org/article/b2cc132fd2b44abca5b9578e25c14238
Autor:
Arzu Gunes, Marja-Liisa Dahl
Publikováno v:
Pharmaceuticals, Vol 3, Iss 4, Pp 782-794 (2010)
Increasing evidence for the role of pharmacogenetics in treatment resistance to the antiplatelet agent clopidogrel has been gained during the last years. Apart from CYP2C19 genetic polymorphisms, nongenetic factors, particularly drug-drug interaction
Externí odkaz:
https://doaj.org/article/9cd94903b16c4eaab91c8bb0e102e356
Autor:
Ludvig Petersson, Christian Schörgenhofer, Ylva Askfors, Hanna Justad, Marja-Liisa Dahl, Marine L. Andersson
Publikováno v:
Drugs & Aging. 40:369-376
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b2321daaa257dd46bb24d775c54f3519
https://doi.org/10.1007/s40266-023-01021-9
https://doi.org/10.1007/s40266-023-01021-9